NCT00063297已完成2 期
Safety and Efficacy of Study Drug Versus Placebo for Negative Symptoms of Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.29 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2003年5月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 180
- 试验地点
- 29
研究概览
简要总结
This study is to determine the efficacy (how well the drug works), safety, and side effects of the study medication compared to placebo in the treatment of the negative symptoms of schizophrenia in adults.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adults aged 18-60
- •Current diagnosis of schizophrenia
- •Significant negative symptoms with few positive symptoms (e.g. hallucinations, delusions) and no evidence of major depression.
- •Female subjects of childbearing potential must test negative for pregnancy at the time of enrollment.
- •Subjects must be able to provide consent
- •Must be healthy based on medical exam, laboratory tests and electrocardiogram
排除标准
- •Female subjects who are either pregnant or nursing.
- •Acute or unstable medical conditions
- •Diseases of the central nervous system
- •Subjects who are judged clinically to be at serious risk for suicide or violence
- •Subjects with delusional disorder, psychotic disorder NOS, schizophreniform, schizoaffective disorder, bipolar disorder, attention deficit/hyperactivity disorder, major depressive disorder,alcohol or drug dependence
研究者
研究点 (29)
Loading locations...
相似试验
已完成
2 期
Treatment of Cognitive Impairment in Men With Schizophrenia (MK5757-005)(COMPLETED)SchizophreniaNCT00848484Merck Sharp & Dohme LLC54
已完成
2 期
Safety and Efficacy of an Anti-Psychotic in Patients With SchizophreniaSchizophreniaNCT00074477Johnson & Johnson Pharmaceutical Research & Development, L.L.C.250
已完成
不适用
A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic DermatitisMild to Moderate Atopic DermatitisNCT05057351Greenpharma S.A.S.44
已完成
3 期
Efficacy and Safety of a Long Acting Anti-Psychotic Versus Placebo in Patients With SchizophreniaSchizophreniaNCT00101634Johnson & Johnson Pharmaceutical Research & Development, L.L.C.518
已完成
3 期
A Study of Vonapanitase (PRT-201) Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-2)Chronic Kidney DiseaseNCT02414841Proteon Therapeutics696